{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:48:23Z","timestamp":1793760503630,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s12185-008-0120-5","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T02:42:49Z","timestamp":1214880169000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":514,"title":["Body iron metabolism and pathophysiology of iron overload"],"prefix":"10.1007","volume":"88","author":[{"given":"Yutaka","family":"Kohgo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Torimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,2]]},"reference":[{"key":"120_CR1","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","volume":"341","author":"NC Andrews","year":"1999","unstructured":"Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986\u201395.","journal-title":"N Engl J Med"},{"key":"120_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1042\/bst0300722","volume":"30","author":"AT McKie","year":"2002","unstructured":"McKie AT, Latunde-Dada GO, Miret S, et al. Molecular evidence for the role of a ferric reductase in iron transport. Biochem Soc Trans. 2002;30:722\u20134.","journal-title":"Biochem Soc Trans"},{"key":"120_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/gut.51.2.290","volume":"51","author":"D Trinder","year":"2002","unstructured":"Trinder D, Fox C, Vautier G, Olynyk JK. Molecular pathogenesis of iron overload. Gut. 2002;51:290\u20135.","journal-title":"Gut"},{"key":"120_CR4","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.2174\/092986705774462969","volume":"12","author":"PJ Sargent","year":"2005","unstructured":"Sargent PJ, Farnaud S, Evans RW. Structure\/function overview of proteins involved in iron storage and transport. Curr Med Chem. 2005;12:2683\u201393.","journal-title":"Curr Med Chem"},{"key":"120_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.beha.2004.10.003","volume":"18","author":"ZI Cabantchik","year":"2005","unstructured":"Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18:277\u201387.","journal-title":"Best Pract Res Clin Haematol"},{"key":"120_CR6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V89.3.739","volume":"89","author":"NF Olivieri","year":"1997","unstructured":"Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739\u201361.","journal-title":"Blood"},{"key":"120_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJM200008033430503","volume":"343","author":"E Angelucci","year":"2000","unstructured":"Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343:327\u201331.","journal-title":"N Engl J Med"},{"key":"120_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1357-2725(03)00258-9","volume":"36","author":"K Ikuta","year":"2004","unstructured":"Ikuta K, Zak O, Aisen P. Recycling, degradation and sensitivity to the synergistic anion of transferrin in the receptor-independent route of iron uptake by human hepatoma (HuH\u20137) cells. Int J Biochem Cell Biol. 2004;36:340\u201352.","journal-title":"Int J Biochem Cell Biol"},{"key":"120_CR9","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1073\/pnas.0606424103","volume":"103","author":"JP Liuzzi","year":"2006","unstructured":"Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci USA. 2006;103:13612\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"120_CR10","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1182\/blood-2005-05-1809","volume":"107","author":"M Schranzhofer","year":"2006","unstructured":"Schranzhofer M, Schifrer M, Cabrera JA, et al. Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood. 2006;107:4159\u201367.","journal-title":"Blood"},{"key":"120_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/shem.2002.35637","volume":"39","author":"MD Fleming","year":"2002","unstructured":"Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol. 2002;39:270\u201381.","journal-title":"Semin Hematol"},{"key":"120_CR12","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1074\/jbc.M008922200","volume":"276","author":"CH Park","year":"2001","unstructured":"Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806\u201310.","journal-title":"J Biol Chem"},{"key":"120_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.hepres.2005.08.005","volume":"33","author":"J Inamura","year":"2005","unstructured":"Inamura J, Ikuta K, Jimbo J, et al. Upregulation of hepcidin by interleukin-1beta in human hepatoma cell lines. Hepatol Res. 2005;33:198\u2013205.","journal-title":"Hepatol Res"},{"key":"120_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00062752-200407000-00004","volume":"11","author":"T Ganz","year":"2004","unstructured":"Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol. 2004;11:251\u20134.","journal-title":"Curr Opin Hematol"},{"key":"120_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0140-6736(03)12602-5","volume":"361","author":"KR Bridle","year":"2003","unstructured":"Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361:669\u201373.","journal-title":"Lancet"},{"key":"120_CR16","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/hep.21886","volume":"46","author":"A Pietrangelo","year":"2007","unstructured":"Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology. 2007;46:1291\u2013301.","journal-title":"Hepatology"},{"key":"120_CR17","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1182\/blood-2006-09-048868","volume":"109","author":"S Gardenghi","year":"2007","unstructured":"Gardenghi S, Marongiu MF, Ramos P, et al. Ineffective erythropoiesis in \u03b2-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007;109:5027\u201335.","journal-title":"Blood"},{"key":"120_CR18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood.V66.4.935.935","volume":"66","author":"M Cazzola","year":"1985","unstructured":"Cazzola M, Huebers HA, Sayers MH, MacPhail AP, Eng M, Finch CA. Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans. Blood. 1985;66:935\u20139.","journal-title":"Blood"},{"key":"120_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0955-3886(00)00087-4","volume":"23","author":"W Breuer","year":"2000","unstructured":"Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci. 2000;23:185\u201392.","journal-title":"Transfus Sci"},{"key":"120_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/13813450701318583","volume":"113","author":"AM Koorts","year":"2007","unstructured":"Koorts AM, Viljoen M. Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem. 2007;113:30\u201354.","journal-title":"Arch Physiol Biochem"},{"key":"120_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","volume":"1275","author":"PM Harrison","year":"1996","unstructured":"Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275:161\u2013203.","journal-title":"Biochim Biophys Acta"},{"key":"120_CR22","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/jcp.25.11.1003-a","volume":"25","author":"A Jacobs","year":"1972","unstructured":"Jacobs A, Beamish MR, Allison M. The measurement of circulating ferritin. J Clin Pathol. 1972;25:1003.","journal-title":"J Clin Pathol"},{"key":"120_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/bmj.4.5834.206","volume":"4","author":"A Jacobs","year":"1972","unstructured":"Jacobs A, Miller F, Worwood M, Beamish MR, Wardrop CA. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J. 1972;4:206\u20138.","journal-title":"Br Med J"},{"key":"120_CR24","first-page":"447","volume":"83","author":"A Piperno","year":"1998","unstructured":"Piperno A. Classification and diagnosis of iron overload. Haematologica. 1998;83:447\u201355.","journal-title":"Haematologica"},{"key":"120_CR25","first-page":"1317","volume":"20","author":"H Saito","year":"1979","unstructured":"Saito H, Hayashi D, Ohya T, Ohya F, Yamada H. Clinical evaluation on serum ferritin (author\u2019s transl). Rinsho Ketsueki. 1979;20:1317\u201325.","journal-title":"Rinsho Ketsueki"},{"key":"120_CR26","first-page":"1343","volume":"91","author":"R Galanello","year":"2006","unstructured":"Galanello R, Piga A, Forni GL, et al. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in paediatric patients with \u03b2-thalassaemia major. Haematologica. 2006;91:1343\u201351.","journal-title":"Haematologica"},{"key":"120_CR27","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","volume":"107","author":"MD Cappellini","year":"2006","unstructured":"Cappellini MD, Cohen A, Piga A, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455\u201362.","journal-title":"Blood"},{"key":"120_CR28","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1182\/blood-2002-09-2754","volume":"101","author":"PD Jensen","year":"2003","unstructured":"Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood. 2003;101:4632\u20139.","journal-title":"Blood"},{"key":"120_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1600-0609.2007.00842.x","volume":"78","author":"M Takatoku","year":"2007","unstructured":"Takatoku M, Uchiyama T, Okamoto S, et al. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity\/mortality. Eur J Haematol. 2007;78:487\u201394.","journal-title":"Eur J Haematol"},{"issue":"Suppl 3","key":"120_CR30","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/S0145-2126(07)70461-7","volume":"31","author":"N Gattermann","year":"2007","unstructured":"Gattermann N. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload. Leuk Res. 2007;31(Suppl 3):S10\u20135.","journal-title":"Leuk Res"},{"key":"120_CR31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJM199504063321404","volume":"332","author":"NF Olivieri","year":"1995","unstructured":"Olivieri NF, Brittenham GM, Matsui D, et al. Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med. 1995;332:918\u201322.","journal-title":"N Engl J Med"},{"key":"120_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00004728-198004000-00005","volume":"4","author":"JA Long Jr","year":"1980","unstructured":"Long JA Jr, Doppman JL, Nienhus AW, Mills SR. Computed tomographic analysis of beta-thalassemic syndromes with hemochromatosis: pathologic findings with clinical and laboratory correlations. J Comput Assist Tomogr. 1980;4:159\u201365.","journal-title":"J Comput Assist Tomogr"},{"key":"120_CR33","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJM198212303072703","volume":"307","author":"GM Brittenham","year":"1982","unstructured":"Brittenham GM, Farrell DE, Harris JW, et al. Magnetic-susceptibility measurement of human iron stores. N Engl J Med. 1982;307:1671\u20135.","journal-title":"N Engl J Med"},{"key":"120_CR34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","volume":"127","author":"LJ Anderson","year":"2004","unstructured":"Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004;127:348\u201355.","journal-title":"Br J Haematol"},{"key":"120_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0162-0134(02)00461-0","volume":"91","author":"RR Crichton","year":"2002","unstructured":"Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem. 2002;91:9\u201318.","journal-title":"J Inorg Biochem"},{"key":"120_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.amjmed.2005.10.041","volume":"119","author":"AW Yen","year":"2006","unstructured":"Yen AW, Fancher TL, Bowlus CL. Revisiting hereditary hemochromatosis: current concepts and progress. Am J Med. 2006;119:391\u20139.","journal-title":"Am J Med"},{"key":"120_CR37","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMra031573","volume":"350","author":"A Pietrangelo","year":"2004","unstructured":"Pietrangelo A. Hereditary hemochromatosis\u2014a new look at an old disease. N Engl J Med. 2004;350:2383\u201397.","journal-title":"N Engl J Med"},{"key":"120_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng0896-399","volume":"13","author":"JN Feder","year":"1996","unstructured":"Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399\u2013408.","journal-title":"Nat Genet"},{"key":"120_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ajh.20493","volume":"81","author":"M Franchini","year":"2006","unstructured":"Franchini M. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment. Am J Hematol. 2006;81:202\u20139.","journal-title":"Am J Hematol"},{"key":"120_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0741-8329(03)00127-7","volume":"30","author":"HL Bonkovsky","year":"2003","unstructured":"Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol. 2003;30:137\u201344.","journal-title":"Alcohol"},{"key":"120_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","volume":"2","author":"MG Zurlo","year":"1989","unstructured":"Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2:27\u201330.","journal-title":"Lancet"},{"key":"120_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0002-8703(03)00248-5","volume":"146","author":"JH McGowan","year":"2003","unstructured":"McGowan JH, Cleland JG. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J. 2003;146:388\u201397.","journal-title":"Am Heart J"},{"key":"120_CR43","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"LJ Anderson","year":"2001","unstructured":"Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171\u20139.","journal-title":"Eur Heart J"},{"key":"120_CR44","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1046\/j.1365-2141.2000.02298.x","volume":"110","author":"PT Telfer","year":"2000","unstructured":"Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110:971\u20137.","journal-title":"Br J Haematol"},{"key":"120_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJM199907083410207","volume":"341","author":"NF Olivieri","year":"1999","unstructured":"Olivieri NF. The \u03b2-thalassemias. N Engl J Med. 1999;341:99\u2013109.","journal-title":"N Engl J Med"},{"key":"120_CR46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1365-2141.2006.06332.x","volume":"135","author":"EB Fung","year":"2006","unstructured":"Fung EB, Harmatz PR, Lee PD, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006;135:574\u201382.","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-008-0120-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12185-008-0120-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:27:00Z","timestamp":1707740820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-008-0120-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0120-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"30 April 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}